LY4064809 for Healthy Adults

Tq
Pi
Overseen ByPhysicians interested in becoming principal investigators please contact
Age: 18 - 65
Sex: Any
Trial Phase: Phase 1
Sponsor: Eli Lilly and Company
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to find out how much LY4064809 gets into the blood stream and how long it takes the body to get rid of it when it is given as two formulations. For each participant, the study will last about nine weeks. Participants will remain in the clinical research center for about one month.

Who Is on the Research Team?

C1

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

Principal Investigator

Eli Lilly and Company

Are You a Good Fit for This Trial?

This trial is for healthy adults with normal blood pressure, pulse rate, and clinical lab results. Participants must have a BMI of 18-32 kg/m2 and not be able to bear children. They should pass a medical evaluation including history, physical exam, vital signs, and ECG.

Inclusion Criteria

I am healthy based on a recent medical check-up and tests.
My BMI is between 18 and 32.
My blood pressure and pulse are within normal ranges or not concerning.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive LY4064809 in two formulations to assess bioavailability

4 weeks
Participants remain in the clinical research center

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • LY4064809

Trial Overview

The study tests how much of the drug LY4064809 enters the bloodstream and its elimination time using two different formulations. Each participant will be involved in the study for about nine weeks with a one-month stay at the research center.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: LY4064809 TestExperimental Treatment2 Interventions
Group II: LY4064809 ReferenceExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Eli Lilly and Company

Lead Sponsor

Trials
2,708
Recruited
3,720,000+
Dr. Daniel Skovronsky profile image

Dr. Daniel Skovronsky

Eli Lilly and Company

Chief Medical Officer since 2018

MD from Harvard Medical School

David A. Ricks profile image

David A. Ricks

Eli Lilly and Company

Chief Executive Officer since 2017

BSc from Purdue University, MBA from Indiana University